McGovern improves national ranking in NIH funding
McGovern Medical School has increased its National of Institutes of Health funding, reaching the top 35 percent of U.S. medical schools. With a total of $122,058,619 in NIH funding in 2024, McGovern is listed as 51st among all U.S. medical schools according to the Blue Ridge Institute for Medical Research.
“These numbers are testament to our prolific and outstandingly talented faculty who are making a real impact in basic, translational and clinical research,” said Executive Dean John Hancock.
The national ranking is McGovern’s highest place since 2002, when it was ranked as 50th in NIH funding.
Specific Medical School departments also are ranked among their peer departments in NIH research funding, with four McGovern departments in the national top 10: Anesthesiology (8), Integrative Biology and Pharmacology (Physiology) (9), Neurosurgery (5), and Physical Medicine and Rehabilitation (9).
A total of 12 McGovern Medical School departments, out of 20 that have historically been ranked over the last 9 years, improved their NIH funding rank when nationally compared to their peer departments over last year. These include the departments of Anesthesiology, Emergency Medicine, Family Medicine, Integrative Biology and Pharmacology, Microbiology, Neurology, Obstetrics and Gynecology, Ophthalmology, Orthopedics, Pathology, Physical Medicine and Rehabilitation, and Psychiatry.
The Blue Ridge Institute for Medical Research derives all data from NIH composite data for the federal fiscal year ending Sept. 30, 20204, as released on the NIH Research Portfolio Online Reporting Tool.